A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation
Ad GV.EGR.TNF.11D（TNFerade™ Biologic）联合放化疗治疗复发性头颈癌并接受再放疗的患者的第一阶段剂量递增研究
期刊:Annals of Oncology
影响因子:56.7
doi:10.1093/annonc/mds523
T Y Seiwert, T Darga, D Haraf, E A Blair, K Stenson, E E W Cohen, J K Salama, V Villaflor, M E Witt, M W Lingen, R R Weichselbaum, E E Vokes
